groups have a heterogeneous genetic architecture. NSCL/P comprises nonsyndromic cleft lip only (NSCL) and nonsyndromic cleft lip and palate (NSCLP; Dixon et al. 2011) .
To date, 6 genome-wide association studies (GWASs) and a meta-analysis have been published for NSOFCs, with these signals demonstrating an association with NSCL/P but not NSCPO. In a GWAS involving Europeans, an association was observed between a locus in Chr8q.24 and NSCL/P (Birnbaum et al. 2009 ). The 8q.24 signal was subsequently replicated in another GWAS of NSCL/P in Europeans from the United States (Grant et al. 2009) . A third GWAS that involved cohorts of European ancestries also revealed that 2 additional loci, 17q22 (NOG1) and 10q25 (VAX1), were associated with NSCL/P. Other loci yielded a suggestive association with NSCL/P: 15q13.3 (GREM1), 13q31.1 (SPRY2), and 2p21 (THADA; Mangold et al. 2010) . Employing trios of Asian and European ancestries, a GWAS implicated 20q12 (MAFB) and 1p22.1 (ABCA4) in the etiology of NSCL/P, with 17p13 (NTN1) showing a suggestive association. Stratified analyses based on ancestries by the same GWAS showed that some signals were ancestry specific: trios of European ancestry gave the strongest association for 8q.24, whereas those of Asian ancestry were strongly associated with MAFB, ABCA4, and IRF6 (Beaty et al. 2010) . A meta-analysis revealed additional NSCL/P susceptibility loci: THADA, SPRY2, 15q22.2 (TPM1), and 1p36 (PAX7; Ludwig et al. 2012) . Recently, a GWAS involving Asians implicated 16p13.3 (ADCY9; Sun et al. 2015) in the etiology of NSCL/P, whereas a GWAS involving dogs and a Guatemalan population gave a suggestive association for ADAMTS20 (Wolf et al. 2015) .
In the pre-and post-GWAS era, candidate gene and replication studies have been instrumental in identifying cleft susceptibility loci. Pathogenic variants in IRF6 were shown to cause van der Woude syndrome and popliteal pterygium syndrome (Kondo et al. 2002) . Subsequently, a missense variant in IRF6 (rs2235371) demonstrated overtransmission in NSCL/P cases of European ancestry (Zucchero et al. 2004) . Another IRF6 locus, rs642961, has been shown to be associated with NSCL/P but not NSCPO (Rahimov et al. 2008) . Corollary to these observations, some studies (Birnbaum et al. 2009; Kerameddin et al. 2015) have confirmed a role of IRF6 as a NSCL/P risk locus in populations of Asian and European ancestries. Other candidate genes implicated in the etiology of NSCL/P included MSX1 (Rafighdoost et al. 2013) , BMP4 (Suzuki et al. 2009 ), FOXE1 (Moreno et al. 2009 ), AXIN2 (Letra et al. 2012) , CRISPLD2 (Chiquet et al. 2007) , NOG1, and FGFR2 .
Among Africans, genetic studies on OFCs are limited. A study involving a Nigerian cohort implicated MSX1, but not other loci, in the etiology of NSCL/P (Butali et al. 2011) . Other studies that recruited Kenyans (Weatherley-White et al. 2011) and Congolese (Figueiredo et al. 2014) could not replicate the association for cleft susceptibility loci among Africans, probably due to the small sample size and population heterogeneity. Moreover, sequencing of GWAS loci in cohorts from Ethiopia and Nigeria reported some rare, potentially causative variants . Conducting genetic and genomics studies with a cleft cohort from Africa may identify novel and population-specific signals. However, it is also important for us to investigate the role of identified signals and biologically relevant genes from existing European and Asian studies in the African population. The present study aimed to replicate the association between reported GWASs and candidate gene loci in our NSCL/P cohort. We also tested the hypothesis that NSCL/P loci may contribute to NSCPO susceptibility in Africans. Finally, we screened for rare, potentially pathogenic variants in 7 candidate genes at risk loci usually associated with NSCL/P.
Subjects and Methods
We recruited 3,585 participants from Ghana, Ethiopia, and Nigeria (Table 1 ; Appendix Methods). All sample and data collection at various study sites were approved by the local institutional review boards: College of Health Sciences, KNUST (Ghana; CHRPE/AP/217/13); College of Medicine, University of Lagos (Nigeria; ADM/DCST/HREC/APP/1374); and College of Health Sciences, Addis Ababa University (Ethiopia; 3.10/ 027/2015). Before sample and data collection, written informed consent was obtained from each participating family. DNA processing is shown in the Appendix Methods.
Single-Nucleotide Polymorphism Selection
We selected single-nucleotide polymorphisms (SNPs) with a minor allele frequency (MAF) ≥5% in the African population for genotyping; these were previously reported in peer review journals or identified in animal studies and during our resequencing studies. These include SNPs that are associated with NSCL/P in candidate genes studies and GWASs in European and Asian populations (Appendix Table 1 ).
SNP Genotyping
We genotyped 48 SNPs (Appendix Table 1 ) on a total of 3,585 samples-872 NSOFC cases (163 NSCPO, 340 NSCL, 361 NSCLP, and 8 "untyped"), 1,635 unaffected relatives, and 1,078 unrelated controls-with the 192.24 Fluidigm SNP genotyping protocol (Appendix Methods). The "untyped" samples (from probands) and other samples, however, failed quality control checks and were not included in the final statistical analyses (Table 1) .
Statistical Analyses for Association Studies
During quality control checks, we resolved Mendelian errors in case-parent triads and dropped from the final analyses samples that were not successfully genotyped on at least 95% of the 48 genotyped SNPs. We computed Hardy-Weinberg equilibrium (HWE) through PLINK (http://pngu.mgh.harvard .edu/~purcell/plink/). We then conducted 1) case-control analyses to determine associations in each subpopulation and 2) meta-analyses of the 3 subpopulations based on Table 1 . For this test, we used P < 0.05 to denote nominal association and a Bonferroni correction of 141 tests to ascertain a threshold for formal significance of P = 3.54 × 10 -4 . The 141 tests comprised 47 SNPs that passed HWE × 3 cleft subphenotypes × 1 racial group × 1 test. Of the 48 SNPs, only 1 failed HWE (P < 0.05). Additional analyses to determine overtransmission of the rare alleles were conducted with the transmission disequilibrium test (TDT) and through the family-based association for disease traits (DFAM). The TDT used only the case-parent triad information (Table 1) , while the DFAM allowed us to combine triad and dyad data. For these tests, the significant P value was 0.05. Parent-of-origin effects and gene-gene interactions (epistasis) were also calculated. The probands in the case-control arm of the study (Table 1) are the same probands in the familybased studies.
DNA Sequencing
We directly sequenced VAX1, PAX7, ARHGAP29, MSX1, FOXE1, BMP4, and MAFB in 184 NSOFC cases (131 NSCL/P and 53 NSCPO) from Ghana using Sanger Sequencing (Appendix Methods; . We also performed segregation Case probands consisted of 423 males and 441 females, whereas unrelated controls were made up of 441 males and 637 females. The probands in the case-control arm of the study are the same probands in the family-based studies. In some of the designated singletons, parental samples failed data cleaning and were dropped from statistical analyseshence, the designation of such families as singletons. Singletons were informative in the case-control arm of our study but not the familybased studies. Tetrads and pentads were collected from families where 2 individuals were affected with clefts. "Other trios and dyads" largely refers to case-mother-maternal grandmother trios, case-mother-sibling trios, as well as case-siblings trios and dyads. Case-parent trios, tetrads, and pentads were employed in the transmission disequilibrium test, whereas all sample types, except singletons and unrelated controls, were used for analyses of the family-based association for disease traits. Only case probands and unrelated controls were included in the case-control analyses. NSCL, nonsyndromic cleft lip; NSCL/P, nonsyndromic cleft lip with or without cleft palate; NSCLP, nonsyndromic cleft lip and palate; NSCPO, nonsyndromic cleft palate only.
analyses on observed potentially pathogenic missense, frameshift, and splice site variants by sequencing available parental samples. We further sequenced 96 unrelated Ghanaian controls to ascertain whether the novel variants that we encountered in NSOFC cases also occurred in controls.
Results

Association Analyses
In meta-analyses of the case-control cohorts from the 3 subpopulations, we successfully demonstrated nominal association of PAX7 (rs742071, P = 5.10 × 10 -3 ), 8q24 (rs987525, P = 1.22 × 10 -3 ), as well as VAX1 (rs7078160, P = 0.04) with NSCL/P; in addition, MSX1 (rs115200552, P = 0.01), TULP4 (rs651333, P = 0.04), CRISPLD2 (rs4783099, P = 0.02), and NOG1 (rs17760296, P = 0.04) were nominally associated with NSCPO (Table 2) , with the direction of effect being the same as reported by earlier studies. Among Ethiopians (Appendix Table 2 ), PAX7 (rs742071, P = 5.57 × 10 -3 ), IRF6 (rs642961, P = 0.02), DYSF (rs2303596, P = 2.31 × 10 -3 ), 8q24 (rs987525, P = 7.82 × 10 -4 ), and MAFB (rs13041247 and rs11696257, all with P = 0.04) were nominally associated with NSCL/P; ABCA4 (rs481931 and rs4147811, all with P = 0.03) and NTN1 (rs8081823, P = 0.03) were nominally associated with NSCPO. Moreover, subphenotype analyses of the Ethiopian NSCL/P cohort showed that the PAX7, DYSF, MSX1, SPRY2 (rs9574565, P = 7.05 × 10 -3 ) and MAFB signals were particularly stronger for NSCL, whereas the IRF6 (rs642961, P = 9.11 × 10 -3 ) and 8q24 (rs987525, P = 1.07 × 10 -3 ) signals were stronger for NSCLP (Appendix Table 2 ). Among Ghanaians (Appendix Table 3 ), ABCA4 (rs560426, P = 0.03) and VAX1 (rs7078160, P = 0.03) were nominally associated with NSCL/P with subphenotype analyses of the NSCL/P cohort showing that the ABCA4 locus was strongly associated with NSCLP. ABCA4 (rs4147811, P = 7.48 × 10 -3 ) and CRISPLD2 (rs4783099, P = 0.04) were nominally associated with NSCL/P and NSCPO, respectively, among Nigerians (Appendix Table 4 ). Subphenotype analyses of the Nigerian NSCL/P (Appendix Table 4 ) showed that PAX7 (rs742071, P = 0.02) and ARHGAP29 (rs138751793, P = 0.04) signals were stronger for NSCL, whereas another SNP at the ABCA4 locus (rs481931, P = 2.87 × 10 -3 ) was strongly associated with NSCLP. However, none of these casecontrol associations passed Bonferroni correction. For the TDT and DFAM (Tables 3 and 4 ) for all 3 subpopulations, 7 loci demonstrated formal significance with NSOFCs at P ≤ 0.05. Formal significance for the TDT and DFAM was evaluated at P ≤ 0.05 because these are secondary analyses compared with case-control analyses and are not true independent tests. All family-based studies suggested that the minor allele of ABCA4 (rs560426) was overtransmitted in NSCLP cases among Africans. PAX7 (rs742071) also consistently showed evidence of overtransmission in NSCL cases in the TDT and DFAM. MSX1 (rs115200552) and AXIN2 (rs3923086) also demonstrated strong overtransmission in NSCLP cases in DFAM analyses, whereas MTHFR (rs1801131) and DYSF exhibited overtransmission in NSCL cases in TDT and DFAM analyses, respectively. Only an SNP of VAX1 demonstrated overtransmission in NSCPO cases.
Parent-of-Origin Effects
Parent-of-origin effects were not observed for almost all SNPs, except rs16260 of CDH1. For rs16260, a trend toward association (P = 0.0764) was observed for all clefts. The rs16260 SNP exhibited a maternal imprinting or maternal overtransmission effect.
Gene-Gene Interactions
In gene-gene (G × G) or epistatic interactions, 3 SNPs exhibited evidence of epistasis with other SNPs. Each of these epistatic interactions yielded P = 0.02. A SNP for ABCA4, rs560426, interacted with Chr6, rs2674394 (gene desert). Moreover, rs2303596 of DYSF interacted with rs3923086 of AXIN2. Finally, rs8069536 of NTN1 interacted with rs17820943, rs13041247, and rs11696257, all of MAFB. However, none of these G × G interactions passed Bonferroni correction.
Direct DNA Sequencing of 7 Selected Genes
We observed several rare and/or novel variants in the 7 genes that we sequenced (Table 5 , Appendix Table 5 ). "Rare variants," as used here, refer to either a novel variant or a variant whose MAF is ≤1%. Some of these variants were predicted to be potentially pathogenic by various bioinformatics tools, whereas others were depicted as benign. A de novo occurrence could not be demonstrated for any of these variants, because either the variant was present in at least 1 parent, or not both parents were available for segregation analysis. Last, some of the novel variants that we observed occurred in controls (e.g., all VAX1 variants), whereas others were not observed in controls (e.g., all ARHGAP29 variants).
Discussion
We have successfully demonstrated associations (both nominal in case-control analyses and threshold in the TDT and DFAM analyses) between some loci and NSCL/P in cohorts from Africa. We also tested the hypothesis that these loci contribute to NSCPO in Africans, and we observed some interesting associations. The 8q24 locus exhibited the strongest nominal significance with NSCL/P in case-control meta-analyses, with the trends suggesting that this locus may be relevant in all 3 subpopulations. The test of heterogeneity also largely suggested the absence of heterogeneity at this locus among the 3 African populations. We observed that among Africans, the associated minor C allele of rs987525 (http://browser.1000 genomes.org) conferred reduced susceptibility, while the major A allele is the risk allele. Irrespective of these differences in minor alleles, our result is in harmony with earlier , though not all studies (Sozen et al. 2009 ) replicated the association. Interestingly, we have demonstrated in TDT analyses that MTHFR is significantly associated with NSCL among Africans and that it is the C minor allele of the A1298C (rs1801131) SNP that confers a reduced risk, suggesting that A is the risk allele. AXIN2 has been implicated in the etiology of NSOFCs in multiple populations, except Africans, with rs3923086 demonstrating an association with NSCLP among Asians (Letra et al. 2012) . Other studies (Mostowska et al. 2012; de Araujo et al. 2015) have replicated the association between AXIN2 and NSCL/P. Here, we have demonstrated that rs3923086 (AXIN2) is also associated with NSCLP among Africans in DFAM analyses. Other candidate genes (e.g., DYSF) also showed evidence of association with NSOFCs among Africans, buttressing the relevance of this approach in etiologic "gene hunting."
Other SNPs, other than the already-reported ones, may be responsible for the associations between certain loci and NSOFCs in some ethnicities. Through direct DNA sequencing of the MSX1 gene, we observed overtransmission of the minor allele of rs115200552 in NSOFC cases. Subsequent genotyping of this SNP in 3,585 individuals showed that this SNP was associated with NSCPO (P = 0.01) in case-control meta-analyses, although family-based studies suggest that this marker may be a risk allele for NSCLP. Earlier studies involving Africans from Nigeria implicated MSX1 in the etiology of NSCL/P (Butali et al. 2011 ).
We could not detect a formal association between some GWASs and candidate gene loci and NSCL/P, presupposing that 1) these loci may not play a role in the etiology of NSCL/P in Africans or 2) the genotyped SNPs may not be the tag SNPs for Africans. Lack of statistical power due to sample size and low MAF of the genotyped SNPs in Africans could also be possible reasons. For example, rs2235371-an SNP of IRF6 that is in high-linkage disequilibrium and the same locus as rs642961 and that has been associated with NSCL/P among mostly Asians (Sun et al. 2015) and in some Europeans (Zucchero et al. 2004 )-does not exist in the African population (http://browser.1000genomes.org/index.html). It is also possible that even when no associations are detected between reported loci and NSOFCs, potentially pathogenic variants may be observed in NSOFC cases. Therefore, GWASs and whole genome sequencing of NSOFC cases from Africa are required to detect more risk loci.
Subphenotype and subpopulation analyses (even among the same racial group) may be crucial in detecting an association between certain loci and NSOFCs. In both TDT and DFAM analyses, we observed that rs560426 of ABCA4 was associated with NSCLP but not the other OFC subphenotypes. Casecontrol analyses further suggested that the ABCA4 locus may be crucial in NSOFC etiology in all 3 African populations. PAX7 (rs742071) exhibited nominal association with NSCL/P in case-control meta-analyses, with subpopulation analyses suggesting that this signal originated mainly from the Ethiopian and Nigerian cohorts that exhibited some level of heterogeneity. However, TDT and DFAM subphenotype analyses demonstrated that rs742071 exhibited overtransmission in NSCL cases in all 3 populations. In case-control meta-analyses, VAX1 (rs7078160) was nominally associated with NSCL/P, with subpopulation analyses suggesting the 2 West African countries (largely Ghana) drive this signal. Rare variants, but not necessarily common variants, may account for the link between certain loci and NSOFCs. We observed many missense mutations and 1 frameshift mutation in sequenced genes. No de novo occurrence was observed for any of these variants due to the unavailability of some parental samples. Moreover, some of the novel variants were also observed in clinically unaffected parents and controls. We sequenced the novel variants in 96 controls from Ghana, and the likelihood of identifying these novel variants in more controls (i.e., >96) is possible. Nonetheless, these variants are absent in >1,000 individuals in the 1000 Genomes database (with >300 Africans), >61,000 individuals in the ExAC database, as well as 6,500 individuals in the EVS database. There is also the need to functionally validate the pathogenicity or otherwise of these variants in vivo. Rare variants in ARHGAP29 (Leslie et al. 2012) , PAX7 and VAX1 (Butali et al. 2013; Leslie et al. 2015) , BMP4 (Suzuki et al. 2009 ), FOXE1 (Moreno et al. 2009 ), MAFB , and MSX1 (Liang et al. 2012) have been observed in NSOFC cases.
The incidence of OFC in Africans is much lower than in Europeans and Asians (Mossey and Modell 2012; , even though these populations may share the same or similar genetic susceptibility loci for OFCs, as observed in the present study. Although underascertainment due to a lack of birth defect registries in most African countries could be a contributing factor , the low incidence of OFCs among Africans may be real, as African-derived populations in the Caribbean have a low OFC incidence similar to that of their ancestral population (Mossey and Modell 2012). We therefore hypothesize the possible existence of genetic protective variants in the African genome, whose "rescue mission" reduces clefting. The identification and elucidation of such protective variants can be translated to European and Asian populations to bring about reduced OFC incidence and eventually prevention.
Conclusion
The present study has shown evidence of an association of certain loci with NSOFCs at both nominal and threshold significance. For instance, we have for the first time shown that the 8q.24 locus is a risk locus in Africans. Our study has thus corroborated an earlier suggestion that the 8q24 locus may be a risk locus for NSCL/P across major ethnicities, although the effect size is smaller in Asians due to a lower MAF. Subphenotype as well as subpopulation analyses and genotyping of other SNPs, other than those already reported for some loci, may be crucial in identifying NSOFC loci in various ethnicities and populations. We have also demonstrated the existence of rare variants, both novel and known, in NSOFC cases from Africa. In conclusion, we have for the first time demonstrated associations between the SNPs that we studied and NSOFC among Africans.
Our study is crucial for understanding the genetic architecture of NSOFCs in Africans and further suggests the need to carry out GWASs and whole genome sequencing for every ethnicity as far as complex traits are concerned.
